IRD 10-Q: SEC filing
Opus Genetics, Inc.
Filed with the SEC on · accession 0001628280-26-072697
IRD filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -0.6% by the first close after the filing.
Summary of the filing
Opus Genetics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and corporate developments including the conversion of convertible preferred stock into common stock.
Key details
How IRD stock reacted
Close before
$4.20
Nov 9, 2026
First close after
-0.60%
$4.17
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IRD, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IRD?
Click hereFrequently asked questions
What did IRD file with the SEC on Nov 10, 2026?
IRD filed a 10-Q (SEC filing). Opus Genetics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and corporate developments including the conversion of convertible preferred stock into common stock.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did IRD stock react to this filing?
IRD closed at $4.20 before the filing and $4.17 on Nov 10, 2026 (-0.60%).
Other IRD SEC filings
- 8-K · SEC filingNov 10, 2026
- SCHEDULE 13G · SEC filingOct 27, 2026
- 8-K · Executive departureOct 21, 2026
- 8-K · SEC filingOct 15, 2026
- 8-K · SEC filingSep 11, 2026
- 8-K · Fda approvalSep 9, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- S-3 · Shelf registrationAug 7, 2026
Get alerts when IRD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days